A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis

NCT04040192 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
620
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer